From 29 studies reporting on BRAF mutations in more than 2,000 examined thyroid cancers, the average frequency of mutations in PTC was 44% and in anaplastic thyroid cancer (ATC) was 24% [14]. This evidence concerns the gene BRAF and thyroid gland carcinoma.